Literature DB >> 8289351

Different activation of Epstein-Barr virus immediate-early and early genes in Burkitt lymphoma cells and lymphoblastoid cell lines.

C Bogedain1, P Alliger, F Schwarzmann, M Marschall, H Wolf, W Jilg.   

Abstract

Specific expression of the Epstein-Barr virus (EBV) immediate-early and early gene products Zta, Rta, I'ta, and MSta by a recombinant vaccinia virus system allowed us to analyze the first steps in the induction of the lytic cycle in EBV-infected Burkitt lymphoma (BL) cells and lymphoblastoid cell lines (LCLs). Significant differences in the induction of early genes were found between these cell types: whereas in BL cells the trans activator Zta was found to induce key steps of the early lytic cycle, only minor activities of Zta were noted in LCLs. Contrary to Zta, the trans activator Rta was found to be highly effective in LCLs. These observations suggest that Rta may play an important role in the activation of the early lytic cycle in LCLs, although it cannot be activated by Zta. The latter may be a reason for the lower tendency of LCLs to switch into the lytic cycle compared with BL cells or differentiated epithelial cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8289351      PMCID: PMC236561          DOI: 10.1128/JVI.68.2.1200-1203.1994

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Expression of proteins encoded by Epstein-Barr virus trans-activator genes depends on the differentiation of epithelial cells in oral hairy leukoplakia.

Authors:  J Becker; U Leser; M Marschall; A Langford; W Jilg; H Gelderblom; P Reichart; H Wolf
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

2.  Epstein-Barr virus gene expression in P3HR1-superinfected Raji cells.

Authors:  M Biggin; M Bodescot; M Perricaudet; P Farrell
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

3.  Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA.

Authors:  J Countryman; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

4.  Transfection of a rearranged viral DNA fragment, WZhet, stably converts latent Epstein-Barr viral infection to productive infection in lymphoid cells.

Authors:  E Grogan; H Jenson; J Countryman; L Heston; L Gradoville; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

5.  Expression of the Epstein-Barr virus 138-kDa early protein in Escherichia coli for the use as antigen in diagnostic tests.

Authors:  M Motz; J Fan; R Seibl; W Jilg; H Wolf
Journal:  Gene       Date:  1986       Impact factor: 3.688

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Epstein-Barr virus status and tumour cell phenotype in sporadic Burkitt's lymphoma.

Authors:  M Rowe; C M Rooney; C F Edwards; G M Lenoir; A B Rickinson
Journal:  Int J Cancer       Date:  1986-03-15       Impact factor: 7.396

8.  General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes.

Authors:  M Mackett; G L Smith; B Moss
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

9.  Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkitt lymphoma cell line.

Authors:  Y Hinuma; M Konn; J Yamaguchi; D J Wudarski; J R Blakeslee; J T Grace
Journal:  J Virol       Date:  1967-10       Impact factor: 5.103

10.  Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter.

Authors:  A Chevallier-Greco; E Manet; P Chavrier; C Mosnier; J Daillie; A Sergeant
Journal:  EMBO J       Date:  1986-12-01       Impact factor: 11.598

View more
  13 in total

1.  Nucleoprotein structure of immediate-early promoters Zp and Rp and of oriLyt of latent Epstein-Barr virus genomes.

Authors:  Hans Helmut Niller; Daniel Salamon; Jörg Uhlig; Stefanie Ranf; Marcus Granz; Fritz Schwarzmann; Hans Wolf; Janos Minarovits
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

2.  Sequential use of paraformaldehyde and methanol as optimal conditions for the direct quantification of ZEBRA and rta antigens by flow cytometry.

Authors:  B M Imbert-Marcille; M Coste-Burel; N Robillard; J Foucaud-Gamen; S Billaudel; E Drouet
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

3.  The Epstein-Barr virus LF2 protein inhibits viral replication.

Authors:  Michael A Calderwood; Amy M Holthaus; Eric Johannsen
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

4.  The Epstein-Barr virus Rta protein activates lytic cycle genes and can disrupt latency in B lymphocytes.

Authors:  T Ragoczy; L Heston; G Miller
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

5.  Immediate-early transactivator Rta of Epstein-Barr virus (EBV) shows multiple epitopes recognized by EBV-specific cytotoxic T lymphocytes.

Authors:  S Pepperl; G Benninger-Döring; S Modrow; H Wolf; W Jilg
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

6.  Varied persistent life cycles of Borna disease virus in a human oligodendroglioma cell line.

Authors:  Madiha S Ibrahim; Makiko Watanabe; J Alejandro Palacios; Wataru Kamitani; Satoshi Komoto; Takeshi Kobayashi; Keizo Tomonaga; Kazuyoshi Ikuta
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

7.  Specific cytotoxic T lymphocytes recognize the immediate-early transactivator Zta of Epstein-Barr virus.

Authors:  C Bogedain; H Wolf; S Modrow; G Stuber; W Jilg
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

8.  Epstein-Barr virus lytic replication is controlled by posttranscriptional negative regulation of BZLF1.

Authors:  N Prang; H Wolf; F Schwarzmann
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

9.  Epstein-Barr virus infection of human astrocyte cell lines.

Authors:  A Menet; C Speth; C Larcher; W M Prodinger; M G Schwendinger; P Chan; M Jäger; F Schwarzmann; H Recheis; M Fontaine; M P Dierich
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

10.  Role of the epstein-barr virus RTA protein in activation of distinct classes of viral lytic cycle genes.

Authors:  T Ragoczy; G Miller
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.